复方丹参滴丸治疗冠心病心绞痛的Meta 分析.pdf.pdf

2013 年第 30 卷第 1 期
复方丹参滴丸治疗冠心病心绞痛的 Meta 分析
肖瑜,刘永军*
�, �
中国药科大学国际医药商学院江苏南京 211198
, �
[摘要] 目的�以消心痛治疗作为对照组评价复方丹参滴丸治疗冠心病心绞痛的临床疗效。方法检索中国期刊全文数据库
����, ,
2000 ~ 2012 年和万方数据医药信息系统 2000 ~ 2012 年按照循证医学的要求对符合纳入标准的文献采用 RevMan5. 0 专
, �
用软件进行 Meta 分析选择心绞痛症状疗效、心电图改善效果作为效应指标。结果对于心绞痛症状疗效的合并 OR 值为 2. 54
��, [ , ]���, [ , ],
P < 0. 00001 95% 的 CI 为 1. 89 3. 42 心电图改善的合并 OR 值为 2. 42 P < 0. 00001 95% 的 CI 为 1. 88 3. 12 差异具有
, �,
统计学意义治疗组均优于对照组。结论复方丹参滴丸较消心痛治疗冠心病心绞痛更有效安全性较高。
����
[关键词] 复方丹参滴丸消心痛冠心病心绞痛 Meta 分析
��
[中图分类号] R972. 3 [文献标识码] A [文章编号] 2095 - 3593 2013 01 - 0032 - 05
Meta-analysis of CSDP for Coronary Heart Disease Angina
, *
XIAO Yu LIU Yong-jun
�, , , �
School of International Pharmaceutical Business China Pharmaceutical University Jiangsu Nanjing 211198 China
[ ] �
Abstract Objective To evaluate the clinical efficacy of the CSDP in the treatment of coronary heart disease angina and use isosor-
���
bide dinitrate treatment as a control group. Methods Retrieve the China Academic Journal 2000 ~ 2012 and Wanfang Data of medical
, ,
information systems according to the requirements of evidence-based medicine Meta-analysis of the literature that met the inclusion crite-
,
ria with the RevMan5. 0 software the effect of angina and the electrocardiogram improvement are selected as the effect indicators. Re-
���, [ , ]�
sults The ang